These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 11478380

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling.
    Rapoport SI.
    Neurochem Res; 1999 Nov; 24(11):1403-15. PubMed ID: 10555781
    [Abstract] [Full Text] [Related]

  • 3. In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism.
    Rapoport SI.
    J Pediatr; 2003 Oct; 143(4 Suppl):S26-34. PubMed ID: 14597911
    [Abstract] [Full Text] [Related]

  • 4. A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis.
    Robinson PJ, Noronha J, DeGeorge JJ, Freed LM, Nariai T, Rapoport SI.
    Brain Res Brain Res Rev; 1992 Oct; 17(3):187-214. PubMed ID: 1467810
    [Abstract] [Full Text] [Related]

  • 5. Selective dopamine receptor stimulation differentially affects [3H]arachidonic acid incorporation, a surrogate marker for phospholipase A2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease.
    Hayakawa T, Chang MC, Rapoport SI, Appel NM.
    J Pharmacol Exp Ther; 2001 Mar; 296(3):1074-84. PubMed ID: 11181943
    [Abstract] [Full Text] [Related]

  • 6. In vivo labeling of brain phospholipids by long-chain fatty acids: relation to turnover and function.
    Rapoport SI.
    Lipids; 1996 Mar; 31 Suppl():S97-101. PubMed ID: 8729102
    [Abstract] [Full Text] [Related]

  • 7. Fatty acid incorporation depicts brain activity in a rat model of Parkinson's disease.
    Hayakawa T, Chang MC, Bell JM, Seeman R, Rapoport SI, Appel NM.
    Brain Res; 1998 Oct 05; 807(1-2):177-81. PubMed ID: 9757030
    [Abstract] [Full Text] [Related]

  • 8. Manoalide, a phospholipase A2 inhibitor, inhibits arachidonate incorporation and turnover in brain phospholipids of the awake rat.
    Grange E, Rabin O, Bell J, Chang MC.
    Neurochem Res; 1998 Oct 05; 23(10):1251-7. PubMed ID: 9804280
    [Abstract] [Full Text] [Related]

  • 9. Intravenously injected radiolabelled fatty acids image brain tumour phospholipids in vivo: differential uptakes of palmitate, arachidonate and docosahexaenoate.
    Nariai T, Greig NH, DeGeorge JJ, Genka S, Rapoport SI.
    Clin Exp Metastasis; 1993 Mar 05; 11(2):141-9. PubMed ID: 8444007
    [Abstract] [Full Text] [Related]

  • 10. Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment.
    Chang MC, Bell JM, Purdon AD, Chikhale EG, Grange E.
    Neurochem Res; 1999 Mar 05; 24(3):399-406. PubMed ID: 10215514
    [Abstract] [Full Text] [Related]

  • 11. [Phospholipase A2 and reacylation of phospholipids].
    Muratova UZ, Bornikov VT, Saatov TS.
    Biokhimiia; 1987 Jul 05; 52(7):1068-71. PubMed ID: 3663745
    [Abstract] [Full Text] [Related]

  • 12. In vivo imaging of fatty acid incorporation into brain to examine signal transduction and neuroplasticity involving phospholipids.
    Rapoport SI, Purdon D, Shetty HU, Grange E, Smith Q, Jones C, Chang MC.
    Ann N Y Acad Sci; 1997 May 30; 820():56-73; discussion 73-4. PubMed ID: 9237449
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2.
    Strokin M, Chechneva O, Reymann KG, Reiser G.
    Neuroscience; 2006 Jun 30; 140(2):547-53. PubMed ID: 16563639
    [Abstract] [Full Text] [Related]

  • 14. Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat.
    Bazinet RP, Rao JS, Chang L, Rapoport SI, Lee HJ.
    Psychopharmacology (Berl); 2005 Oct 30; 182(1):180-5. PubMed ID: 15986187
    [Abstract] [Full Text] [Related]

  • 15. Lithium decreases turnover of arachidonate in several brain phospholipids.
    Chang MC, Grange E, Rabin O, Bell JM, Allen DD, Rapoport SI.
    Neurosci Lett; 1996 Dec 20; 220(3):171-4. PubMed ID: 8994220
    [Abstract] [Full Text] [Related]

  • 16. Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats.
    DeGeorge JJ, Nariai T, Yamazaki S, Williams WM, Rapoport SI.
    J Neurochem; 1991 Jan 20; 56(1):352-5. PubMed ID: 1824784
    [Abstract] [Full Text] [Related]

  • 17. Directed shift of fatty acids from phospholipids to triacylglycerols in HL-60 cells induced by nanomolar concentrations of triethyl lead chloride: involvement of a pertussis toxin-sensitive pathway.
    Krug HF, Culig H.
    Mol Pharmacol; 1991 Apr 20; 39(4):511-6. PubMed ID: 1901939
    [Abstract] [Full Text] [Related]

  • 18. Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.
    Farooqui AA, Horrocks LA.
    J Mol Neurosci; 2001 Apr 20; 16(2-3):263-72; discussion 279-84. PubMed ID: 11478381
    [Abstract] [Full Text] [Related]

  • 19. In vivo approaches and rationale for quantifying kinetics and imaging brain lipid metabolic pathways.
    Rapoport SI.
    Prostaglandins Other Lipid Mediat; 2005 Sep 20; 77(1-4):185-96. PubMed ID: 16099403
    [Abstract] [Full Text] [Related]

  • 20. Membrane lipids in the pathogenesis of brain edema: phospholipids and arachidonic acid, the earliest membrane components changed at the onset of ischemia.
    Bazán NG, Rodríguez de Turco EB.
    Adv Neurol; 1980 Sep 20; 28():197-205. PubMed ID: 6779509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.